Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-02-22 to 2023-06-21
Current total value of award: $1099998.66
Description: MEDICAL RESEARCH AND DEVELOPMENT ARMY STTR PH II PROPOSAL NO. A2-8349 TITLED LONG LASTING DRUG IMPLANTS FOR MALARIA CHEMOPROPHYLAXIS. MODIFICATION P00001 - PROVIDE FUNDING FOR YEAR 2 TO FULLY-FUNDED CONTRACT.